Rational Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Rational Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,000	Closed	-$29K	–	316
2016 Q1	$29K	Buy	+5,000	New	+$34.9K	0.02%	205
2015 Q3	$1.18M	Hold	64,000	–	–	0.48%	83
2015 Q2	$1.25M	Sell	64,000 -1,000	-2%	-$17.7K	0.4%	87
2015 Q1	$1.14M	Sell	65,000 -17,000	-21%	-$286K	0.28%	116
2014 Q4	$1.31M	Buy	+82,000	New	+$1.1M	0.26%	115
2013 Q4	$1.32M	Hold	82,000	–	–	0.11%	256
2013 Q3	$1.36M	Hold	82,000	–	–	0.1%	289
2013 Q2	$826K	Buy	+82,000	New	+$862K	0.07%	336

Other funds holding OSIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Rational Advisors's OSIR Position: Q2 2016 in Review

Rational Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2016, closing a stake of 5,000 shares — an estimated $29K sold.

Rational Advisors first reported a position in OSIR in Q2 2013 and held it in 8 quarters. The position peaked at $1.36M in Q3 2013. 68 funds tracked by Wall St. Rank hold OSIR as of Q2 2016.

Rational Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Rational Advisors sold 5,000 Osiris Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $29K.
Rational Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
Rational Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $1.36M in Q3 2013.
68 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Rational Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.